[基于现代病理生理学机制的Chaihu Jia Longgu Muli的临床应用]
Heng-Liang Liu1, Zi-Xuan Jin2, Ke-Lei Su3
1Traditional Chinese Medicine Hospital of Shijiazhuang City Shijiazhuang 050000, China.
概括
传统中医药配方Chaihu Jia Longgu Muli Decoction通过解决复杂的病理生理机制,有效治疗各种心血管,脑血管和精神疾病. 它的现代应用与涉及绍阳和明系统的综合征的古老征兆保持一致.
科学领域:
- 传统中国医药 传统中国医药
- 草药是一种草药.
- 综合医学是一个整体的医学.
背景情况:
- 柴胡贾龙古穆利是一种古典配方,来自"关于寒冷损伤的论文",历史上用于绍阳和明综合征.
- 该研究调查了其传统指示的现代病理生理基础,包括胸部充满,烦,休克,难以排尿,妄想和沉重的身体.
- 这些症状涉及心血管,呼吸,神经和精神系统的复杂功能障碍.
研究的目的:
- 根据现代病理生理学机制解释 Chaihu Jia Longgu Muli Decoction 的经典规定.
- 探索这种配方在治疗各种急性和慢性疾病中的广泛临床应用.
主要方法:
- 分析传统医学文本和现代病理生理学理解.
- 对Chaihu Jia Longgu Muli开的临床应用和适用情况的审查.
- 检查配方组合与其他传统中医药制剂的组合.
主要成果:
- 配方的传统指示具有深刻的病理生理基础,涉及多个器官系统.
- 它被广泛应用于治疗脑血管疾病 (,脑动脉硬化,脑梗塞),心血管疾病 (高血压,心律失常) 和精神疾病 (失眠,焦虑,抑郁,心脏神经症).
- 临床适应症包括特定症状,如胸部/心脏不适,苦味,喉干燥,头,精神症状,以及特征性的舌头和脉发现.
结论:
- 柴胡贾龙古穆利具有广泛的现代疾病的显著治疗潜力.
- 其有效性得到了其病理生理机制和传统指示的深入理解的支持.
- 该配方是整合医学中一个有价值的治疗选择,通常与其他草药配方一起使用.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
22
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
22
01:28Peptic Ulcer Disease II: Pathophysiology
576
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
576
01:17Gastritis-II: Pathophysiology
390
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
390